What’s new in molecular genetic pathology 2022: immune checkpoint inhibitor biomarkers and select solid tumors
Journal of Pathology and Translational Medicine
; : 113-114, 2022.
Article
in En
| WPRIM
| ID: wpr-926147
Responsible library:
WPRO
ABSTRACT
Predictive biomarker testing plays a critical role in targeted immuno-oncology, including the use of immune checkpoint inhibitors (ICI) for various solid tumors. Molecular advancements in cancers of the breast, kidney and brain have continued to propel tumor classification and precision therapy.
Full text:
1
Index:
WPRIM
Language:
En
Journal:
Journal of Pathology and Translational Medicine
Year:
2022
Type:
Article